Copyright Reports & Markets. All rights reserved.

Global Immuno-oncology Drugs Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of Immuno-oncology Drugs

      • 1.1 Definition of Immuno-oncology Drugs
      • 1.2 Immuno-oncology Drugs Segment by Type
        • 1.2.1 Global Immuno-oncology Drugs Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Immune Checkpoint Inhibitors
        • 1.2.3 Monoclonal Antibodies
        • 1.2.4 Cytokine-Based Immunotherapy
        • 1.2.5 Cancer Vaccines
        • 1.2.6 CAR-T Cell Therapy
      • 1.3 Immuno-oncology Drugs Segment by Applications
        • 1.3.1 Global Immuno-oncology Drugs Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Hospitals
        • 1.3.3 Pharmacies
        • 1.3.4 Online Pharmacies
      • 1.4 Global Immuno-oncology Drugs Overall Market
        • 1.4.1 Global Immuno-oncology Drugs Revenue (2014-2025)
        • 1.4.2 Global Immuno-oncology Drugs Production (2014-2025)
        • 1.4.3 North America Immuno-oncology Drugs Status and Prospect (2014-2025)
        • 1.4.4 Europe Immuno-oncology Drugs Status and Prospect (2014-2025)
        • 1.4.5 China Immuno-oncology Drugs Status and Prospect (2014-2025)
        • 1.4.6 Japan Immuno-oncology Drugs Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Immuno-oncology Drugs Status and Prospect (2014-2025)
        • 1.4.8 India Immuno-oncology Drugs Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Immuno-oncology Drugs
      • 2.3 Manufacturing Process Analysis of Immuno-oncology Drugs
      • 2.4 Industry Chain Structure of Immuno-oncology Drugs

      3 Development and Manufacturing Plants Analysis of Immuno-oncology Drugs

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Immuno-oncology Drugs Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Immuno-oncology Drugs
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Immuno-oncology Drugs Production and Capacity Analysis
      • 4.2 Immuno-oncology Drugs Revenue Analysis
      • 4.3 Immuno-oncology Drugs Price Analysis
      • 4.4 Market Concentration Degree

      5 Immuno-oncology Drugs Regional Market Analysis

      • 5.1 Immuno-oncology Drugs Production by Regions
        • 5.1.1 Global Immuno-oncology Drugs Production by Regions
        • 5.1.2 Global Immuno-oncology Drugs Revenue by Regions
      • 5.2 Immuno-oncology Drugs Consumption by Regions
      • 5.3 North America Immuno-oncology Drugs Market Analysis
        • 5.3.1 North America Immuno-oncology Drugs Production
        • 5.3.2 North America Immuno-oncology Drugs Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Immuno-oncology Drugs Import and Export
      • 5.4 Europe Immuno-oncology Drugs Market Analysis
        • 5.4.1 Europe Immuno-oncology Drugs Production
        • 5.4.2 Europe Immuno-oncology Drugs Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Immuno-oncology Drugs Import and Export
      • 5.5 China Immuno-oncology Drugs Market Analysis
        • 5.5.1 China Immuno-oncology Drugs Production
        • 5.5.2 China Immuno-oncology Drugs Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Immuno-oncology Drugs Import and Export
      • 5.6 Japan Immuno-oncology Drugs Market Analysis
        • 5.6.1 Japan Immuno-oncology Drugs Production
        • 5.6.2 Japan Immuno-oncology Drugs Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Immuno-oncology Drugs Import and Export
      • 5.7 Southeast Asia Immuno-oncology Drugs Market Analysis
        • 5.7.1 Southeast Asia Immuno-oncology Drugs Production
        • 5.7.2 Southeast Asia Immuno-oncology Drugs Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Immuno-oncology Drugs Import and Export
      • 5.8 India Immuno-oncology Drugs Market Analysis
        • 5.8.1 India Immuno-oncology Drugs Production
        • 5.8.2 India Immuno-oncology Drugs Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Immuno-oncology Drugs Import and Export

      6 Immuno-oncology Drugs Segment Market Analysis (by Type)

      • 6.1 Global Immuno-oncology Drugs Production by Type
      • 6.2 Global Immuno-oncology Drugs Revenue by Type
      • 6.3 Immuno-oncology Drugs Price by Type

      7 Immuno-oncology Drugs Segment Market Analysis (by Application)

      • 7.1 Global Immuno-oncology Drugs Consumption by Application
      • 7.2 Global Immuno-oncology Drugs Consumption Market Share by Application (2014-2019)

      8 Immuno-oncology Drugs Major Manufacturers Analysis

      • 8.1 Amgen, Inc
        • 8.1.1 Amgen, Inc Immuno-oncology Drugs Production Sites and Area Served
        • 8.1.2 Amgen, Inc Product Introduction, Application and Specification
        • 8.1.3 Amgen, Inc Immuno-oncology Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 AstraZeneca, Plc
        • 8.2.1 AstraZeneca, Plc Immuno-oncology Drugs Production Sites and Area Served
        • 8.2.2 AstraZeneca, Plc Product Introduction, Application and Specification
        • 8.2.3 AstraZeneca, Plc Immuno-oncology Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Bristol-Myers Squibb
        • 8.3.1 Bristol-Myers Squibb Immuno-oncology Drugs Production Sites and Area Served
        • 8.3.2 Bristol-Myers Squibb Product Introduction, Application and Specification
        • 8.3.3 Bristol-Myers Squibb Immuno-oncology Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Celgene Corporation
        • 8.4.1 Celgene Corporation Immuno-oncology Drugs Production Sites and Area Served
        • 8.4.2 Celgene Corporation Product Introduction, Application and Specification
        • 8.4.3 Celgene Corporation Immuno-oncology Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Eli Lilly and Company
        • 8.5.1 Eli Lilly and Company Immuno-oncology Drugs Production Sites and Area Served
        • 8.5.2 Eli Lilly and Company Product Introduction, Application and Specification
        • 8.5.3 Eli Lilly and Company Immuno-oncology Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Merck & Co.
        • 8.6.1 Merck & Co. Immuno-oncology Drugs Production Sites and Area Served
        • 8.6.2 Merck & Co. Product Introduction, Application and Specification
        • 8.6.3 Merck & Co. Immuno-oncology Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Hoffmann-La Roche AG
        • 8.7.1 Hoffmann-La Roche AG Immuno-oncology Drugs Production Sites and Area Served
        • 8.7.2 Hoffmann-La Roche AG Product Introduction, Application and Specification
        • 8.7.3 Hoffmann-La Roche AG Immuno-oncology Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Johnson & Johnson
        • 8.8.1 Johnson & Johnson Immuno-oncology Drugs Production Sites and Area Served
        • 8.8.2 Johnson & Johnson Product Introduction, Application and Specification
        • 8.8.3 Johnson & Johnson Immuno-oncology Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Novartis International AG
        • 8.9.1 Novartis International AG Immuno-oncology Drugs Production Sites and Area Served
        • 8.9.2 Novartis International AG Product Introduction, Application and Specification
        • 8.9.3 Novartis International AG Immuno-oncology Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 AbbVie, Inc.
        • 8.10.1 AbbVie, Inc. Immuno-oncology Drugs Production Sites and Area Served
        • 8.10.2 AbbVie, Inc. Product Introduction, Application and Specification
        • 8.10.3 AbbVie, Inc. Immuno-oncology Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served
      • 8.11 Pfizer Inc.
      • 8.12 Sanofi S.A.
      • 8.13 EMD Serono, Inc.
      • 8.14 Gilead Sciences Inc.
      • 8.15 Prometheus Therapeutics & Diagnostics
      • 8.16 Aduro BioTech
      • 8.17 Galena Biopharma
      • 8.18 Bavarian Nordic
      • 8.19 Celldex Therapeutics
      • 8.20 ImmunoCellular Therapeutics
      • 8.21 Incyte

      9 Development Trend of Analysis of Immuno-oncology Drugs Market

      • 9.1 Global Immuno-oncology Drugs Market Trend Analysis
        • 9.1.1 Global Immuno-oncology Drugs Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Immuno-oncology Drugs Regional Market Trend
        • 9.2.1 North America Immuno-oncology Drugs Forecast 2019-2025
        • 9.2.2 Europe Immuno-oncology Drugs Forecast 2019-2025
        • 9.2.3 China Immuno-oncology Drugs Forecast 2019-2025
        • 9.2.4 Japan Immuno-oncology Drugs Forecast 2019-2025
        • 9.2.5 Southeast Asia Immuno-oncology Drugs Forecast 2019-2025
        • 9.2.6 India Immuno-oncology Drugs Forecast 2019-2025
      • 9.3 Immuno-oncology Drugs Market Trend (Product Type)
      • 9.4 Immuno-oncology Drugs Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Immuno-oncology Drugs Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        The global Immuno-oncology Drugs market was valued at 49200 million US$ in 2018 and will reach 142200 million US$ by the end of 2025, growing at a CAGR of 14.2% during 2019-2025.
        This report focuses on Immuno-oncology Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Immuno-oncology Drugs market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Immuno-oncology Drugs in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Immuno-oncology Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        Amgen, Inc
        AstraZeneca, Plc
        Bristol-Myers Squibb
        Celgene Corporation
        Eli Lilly and Company
        Merck & Co.
        Hoffmann-La Roche AG
        Johnson & Johnson
        Novartis International AG
        AbbVie, Inc.
        Pfizer Inc.
        Sanofi S.A.
        EMD Serono, Inc.
        Gilead Sciences Inc.
        Prometheus Therapeutics & Diagnostics
        Aduro BioTech
        Galena Biopharma
        Bavarian Nordic
        Celldex Therapeutics
        ImmunoCellular Therapeutics
        Incyte

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        Immune Checkpoint Inhibitors
        Monoclonal Antibodies
        Cytokine-Based Immunotherapy
        Cancer Vaccines
        CAR-T Cell Therapy

        Segment by Application
        Hospitals
        Pharmacies
        Online Pharmacies

        Buy now